Brigham Buhler peptides are clinician-prescribed amino acid chains offered through Ways2Well, a telehealth clinic Buhler founded after 15 years as a pharmaceutical sales representative. The protocols cover recovery, fat loss, sleep, hormonal balance, and cognitive performance.
Ways2Well prescribes over eight peptide types including BPC-157, CJC-1295, Ipamorelin, and Tesamorelin. Each protocol starts with a $99 physician consult and bloodwork review. Buhler presented safety data from 75,000 patients to the White House, reporting zero adverse events from physician-guided protocols. The service operates in 46 U.S. states via telehealth.
Most peptides offered remain investigational and lack large-scale human RCT data. This review covers what the protocols include, what patients report, what the evidence shows, and whether the $99 consult is a reasonable starting point for patients who have run out of conventional options.
What Are Brigham Buhler Peptides?
Brigham Buhler peptides are clinician-prescribed amino acid chains used to regulate recovery, metabolism, sleep, and hormonal balance. Ways2Well, founded by Buhler, ships individualized peptide vials with dosing instructions and syringes after a physician-guided consultation.
Here’s the thing: peptides are short chains of amino acids. The body produces them naturally, but lab-synthesized versions can be compounded at regulated pharmacies and prescribed for specific health goals.
Ways2Well operates as a telehealth-based functional medicine clinic. Clinicians review a patient’s labs before prescribing peptides. And it’s available in 46 states across the United States, which is the part most people miss when they first hear about it.
Who Is Brigham Buhler?
Brigham Buhler is a former pharmaceutical sales representative with 15 years of industry experience who founded Ways2Well and co-authored ‘The Peptide Revolution.’ He also operates ReviveRx, a compounding pharmacy that tests every product for FDA compliance and third-party verification.
To be clear, Buhler didn’t just dabble in pharma. He spent over a decade working inside Big Pharma before becoming a vocal critic of its incentive structures. The book ‘The Peptide Revolution,’ co-written with pharmacist-attorney Lee Rosebush, was published in August 2026 by Skyhorse Publishing’s MAHA Books imprint.
He’s appeared on the Joe Rogan Experience twice. He’s presented peptide safety data at the White House. Bottom line: Buhler argues that regulatory restrictions on peptides are driven by pharmaceutical patent interests, not patient safety.
Key Facts About Brigham Buhler:
- Former pharma rep with 15 years of industry experience
- Founder and CEO of Ways2Well functional medicine clinic
- Founder of ReviveRx compounding pharmacy
- Co-author of ‘The Peptide Revolution’ (August 2026, Skyhorse/MAHA Books)
- Appeared twice on the Joe Rogan Experience
- Presented peptide safety data at the White House
Ways2Well provides clinician-guided peptide therapy, advanced diagnostics, IV therapy, stem cell treatments, and formulated supplements based on individual biomarker data. In-person locations operate in Austin and Houston, Texas. Telehealth covers 46 states.
The care plan structure is tiered. Connect, Clarity, and Core are the current options, with Champion coming soon. Each plan starts with comprehensive lab testing to establish a personalized health baseline before any prescriptions are written.
And here’s the best part: the Longevity Lab goes deeper than peptides alone. VO2 Max testing, DEXA scans, qEEG brain mapping. Red light therapy and hyperbaric chambers at the in-person locations. It’s a full-stack health optimization clinic, not just a peptide shop.
How Do Peptides Work?
Peptides act as biological messengers, binding to specific receptors throughout the body and triggering targeted cellular responses without the broad systemic effects of conventional pharmaceuticals. That receptor specificity is what makes peptides different from the blunt instruments most drugs are.
Think of it this way: conventional drugs often scatter-shot across multiple systems. Peptides send targeted signals. A growth hormone-releasing peptide talks directly to the pituitary gland, preserving the body’s own production loop rather than replacing it from outside.
The mechanism varies by peptide type. BPC-157 recruits platelets and growth factors to injury sites. GHK-Cu triggers collagen synthesis at the cellular level. Each peptide targets a distinct biological pathway. That’s why combinations are often prescribed for layered effects.
What Are Peptides Made Of?
Peptides are composed of short amino acid chains, the same building blocks the body uses to make proteins, with lengths typically ranging from 2 to 50 amino acids. Insulin, one of the best-known peptides in medicine, was first used clinically in 1922 and it’s still in widespread use today.
Lab-synthesized peptides are produced in compounding pharmacies under sterile conditions. At ReviveRx, every batch undergoes FDA-compliance testing plus independent third-party verification before dispensing. That’s not standard practice everywhere, which is worth knowing.
The good news? Peptide-based medicine already has mainstream acceptance. GLP-1 drugs like semaglutide and tirzepatide are among the most commercially recognized peptides today. The argument that ‘peptides are fringe medicine’ doesn’t hold up against that reality.
Peptides bind to cell-surface receptors and activate intracellular signaling cascades that regulate gene expression, enzyme activity, and tissue repair without entering the cell nucleus. That extracellular signaling makes peptides highly targetable and reversible in their effects.
Here’s what that actually means: the body’s own peptide production declines with age. Growth hormone secretion drops significantly after 30. Tissue repair peptides decrease over time. Supplemental peptides aim to restore signals that natural aging has quietly dimmed.
Buhler and Rosebush describe peptides as ‘precise signals rather than blunt boosters’ in ‘The Peptide Revolution.’ That framing is useful. Peptides don’t override physiology. They communicate with it.
What Peptides Does Brigham Buhler Recommend?
Buhler’s Ways2Well protocol includes BPC-157, TB-500, CJC-1295, Ipamorelin, Sermorelin, GHK-Cu, Thymosin Alpha, Tesamorelin, and Dihexa, each prescribed based on individual lab results and clinical goals. Nothing is recommended universally. Dosing and combinations depend entirely on bloodwork and patient history.
The process starts with a $99 consult with a Ways2Well physician. Following lab review, the clinician builds a personalized protocol. Then the company ships a full kit: vials, syringes, detailed dosing instructions. It’s delivered to the patient’s door.
And this is where it gets interesting: Buhler’s model contrasts sharply with online vendors selling peptides labeled ‘for research use only.’ Physician oversight and compounding pharmacy quality control aren’t optional extras in his view. They’re the minimum standard for doing this safely.
Peptides in the Ways2Well Formulary:
| Peptide | Primary Use | Delivery |
| BPC-157 | Joint and soft-tissue recovery | Injectable or nasal spray |
| TB-500 | Cellular movement and tissue repair | Injectable |
| CJC-1295 + Ipamorelin | Growth hormone stimulation | Injectable |
| Sermorelin | GH deficiency (FDA approved) | Injectable |
| GHK-Cu | Skin, collagen, hair | Patch or injectable |
| Tesamorelin | Visceral fat reduction | Injectable |
| Dihexa | Cognitive enhancement | Injectable |
| Thymosin Alpha | Immune modulation | Injectable |
What Is BPC-157 Used For?
BPC-157 is a 15-amino-acid peptide derived from gastric juice proteins, prescribed primarily for joint and soft-tissue recovery including knee, hip, shoulder, and rotator cuff injuries. It also targets gut inflammation and intestinal permeability issues.
The mechanism: BPC-157 recruits platelets and growth factors directly to injury sites. That targeted response accelerates tissue repair faster than the body’s unaided healing process, particularly for chronic injuries that have plateaued with conventional treatment.
Now, here’s the honest context: a 2025 University of Utah review describes BPC-157 as ‘investigational,’ noting the absence of large-scale human randomized controlled trials. Most supporting evidence comes from animal studies. TB-500 is often paired with BPC-157 for combined tissue-repair effects.
What Is CJC-1295 and Ipamorelin?
CJC-1295 and Ipamorelin are growth hormone-releasing peptides that stimulate the pituitary gland to secrete more growth hormone, rather than introducing exogenous HGH directly into the bloodstream. That indirect approach preserves the body’s own feedback loop and avoids the risks of external hormone replacement.
In fact, Buhler’s compounding formulation combines CJC-1295 7.5 mg with Ipamorelin 15 mg in a single injectable blend. The combination amplifies each peptide’s individual effect on pituitary GH secretion.
Sermorelin is an FDA-approved alternative in the same class, approved for GH deficiency since 1997. Ipamorelin has not completed human clinical trials. That distinction matters when evaluating the clinical evidence behind each option.
Ways2Well’s extended peptide menu includes GHK-Cu for skin and collagen repair, Thymosin Alpha for immune modulation, Tesamorelin for visceral fat reduction, Dihexa for neurocognitive enhancement, and Epitalon for longevity and telomerase activation. Each is matched to specific biomarker deficiencies identified in lab testing.
GHK-Cu is a copper tripeptide applied via patch or injection, targeting skin elasticity and thinning hair. Buhler combines approximately 10 mg GHK-Cu with 2,000 mcg BPC-157 and 250 mg NAD+ in a single patch formulation for layered regenerative effects.
Here’s what no one tells you about Dihexa: Buhler has cited transformative improvements in neurocognitive function from this peptide in his public discussions. Epitalon, associated with telomerase stimulation, is positioned within anti-aging protocols for patients focused on longevity.
What Are the Benefits of Brigham Buhler Peptides?
Claimed benefits from Ways2Well peptide protocols span fat loss, lean muscle development, accelerated injury recovery, improved sleep quality, hormonal balance, cognitive sharpening, skin renewal, and immune fortification. ‘The Peptide Revolution’ frames these as achievable outcomes grounded in decades of medical use.
Buhler frames it simply: ‘quieter appetite, faster recovery, better sleep, and renewed vitality.’ These four categories represent the most consistently reported outcomes among Ways2Well patients. The book’s documented case examples and Buhler’s public testimony both point to the same pattern.
Pay attention to this: the book explicitly avoids positioning peptides as cure-alls. Buhler and Rosebush stress that peptide therapy works best alongside foundational health pillars. Proper nutrition, consistent movement, adequate recovery, and metabolic health optimization. Peptides amplify a good foundation. They don’t replace one.
Claimed Benefits by Category:
- Fat loss and metabolic health improvement
- Lean muscle development and body composition changes
- Accelerated recovery from chronic injuries
- Improved sleep depth and quality
- Hormonal balance and growth hormone optimization
- Cognitive performance and neurocognitive enhancement
- Skin elasticity, collagen production, and hair health
- Immune system modulation and fortification
Do Peptides Help With Fat Loss and Muscle Growth?
Yes. CJC-1295 and Ipamorelin stimulate pituitary growth hormone secretion, which drives fat mobilization and lean muscle protein synthesis in adults with suboptimal GH levels. And GLP-1 peptides, the same class as semaglutide, are the most commercially validated fat-loss peptides in existence.
Tesamorelin specifically targets visceral fat. That’s the metabolically active abdominal fat linked to cardiovascular and metabolic disease. It represents one of the more targeted fat-reduction peptides in the Ways2Well formulary.
Does this mean anyone can take a peptide and lose weight? No. Results vary based on baseline hormone levels, diet, and exercise habits. Buhler consistently emphasizes that peptides amplify foundational health practices rather than replace them. A patient eating poorly will see limited benefit from GH-releasing peptides alone.
Do Peptides Improve Recovery and Sleep?
Yes. BPC-157 accelerates soft-tissue healing by recruiting platelets and growth factors to injury sites, with Ways2Well reporting zero adverse events across thousands of patients using physician-guided protocols. TB-500 complements BPC-157 by acting on actin-binding pathways for cellular movement and tissue regeneration.
CJC-1295 and Ipamorelin are administered via nightly injection to align with the body’s natural nocturnal growth hormone release. Improved sleep depth is among the most consistently reported effects in this peptide class. The reason is simple: elevated GH during sleep directly supports the tissue repair cycles that happen overnight.
Sermorelin, the FDA-approved alternative, produces brief GH pulses with a 10 to 20 minute half-life. Its shorter activity window during the night cycle mimics natural pulsatile GH secretion more closely than longer-acting alternatives.
Are Brigham Buhler Peptides Safe?
Ways2Well peptides are compounded at FDA-compliant pharmacies with third-party batch testing, but most peptides remain classified as investigational with limited large-scale human RCT data confirming long-term safety. Buhler’s position: adverse events occur primarily with black-market contaminated versions, not pharmaceutical-grade compounded products.
TB-500 and BPC-157 are banned by the World Anti-Doping Agency (WADA) as performance-enhancing substances. That ban signals their biological potency. It doesn’t directly address civilian safety at medical-use dosing levels.
Dr. Eric Topol, a prominent research methods expert, has stated plainly: ‘None of them are proven.’ That characterization reflects the current state of clinical trial evidence, not necessarily the experiential data Buhler has collected from his 75,000-patient population.
What Do 75,000 Patient Records Show?
Buhler presented data from 75,000 patients at the White House showing zero adverse events associated with physician-guided peptide therapy at Ways2Well, a figure he frames as evidence that regulatory restrictions are disproportionate to actual risk. The data covers patients treated through his clinic and compounding pharmacy network.
Here’s the contrast Buhler draws: over 800 peer-reviewed studies support peptide safety. FDA-approved drugs routinely undergo major label changes or market recalls post-approval. Buhler submitted 17 FOIA requests to the FDA requesting the safety data behind the peptide ban. Zero responses received.
Independent researchers caution that observational clinic data differs from controlled trial evidence. Absence of reported adverse events in a clinical setting doesn’t confirm safety across all populations and dosing regimens. Prospective randomized trials remain absent for most of these peptides.
Side effects vary by peptide class: growth hormone releasers can cause water retention, joint discomfort, and temporary insulin resistance, while BPC-157 has reported nausea and dizziness in some animal study extrapolations. GLP-1 peptides are well-documented to cause gastrointestinal disturbance including nausea, vomiting, and diarrhea.
Ipamorelin is considered to have a favorable side effect profile compared to older GH secretagogues. The mechanism avoids cortisol and prolactin stimulation. That distinguishes it from first-generation compounds, though human trial completion remains absent.
This is important: black-market peptides carry substantially higher risk. Overseas suppliers often contain heavy metals. Some products ‘contain no actual peptide at all,’ according to Buhler. Contamination-driven adverse events are the primary documented safety concern in the available literature.
Known Side Effects by Peptide Class:
| Peptide Class | Potential Side Effects | Evidence Level |
| GH Releasers (CJC-1295, Ipamorelin) | Water retention, joint discomfort, insulin resistance | Observational |
| BPC-157 | Nausea, dizziness (animal extrapolation) | Preclinical |
| GLP-1 Peptides | Nausea, vomiting, diarrhea | FDA-documented |
| Black-market sources | Heavy metal contamination, product absence | Documented reports |
What Do Brigham Buhler Peptides Reviews Say?
Patient accounts of Ways2Well peptide protocols consistently highlight improvements in energy, body composition, joint recovery, and sleep quality, with the $99 physician consultation cited as an accessible entry point compared to direct-pay functional medicine. Buhler’s social media following reports similar experiences across multiple peptide classes.
Buhler has shared specific cases publicly. One involved significant weight loss achieved through GLP-1 micro-dosing at doses lower than commercial pharmaceutical products. Another highlighted neurocognitive improvement attributed to Dihexa over a monitored protocol period.
The telehealth-first, lab-guided prescribing model gets consistent praise for combining clinical oversight with real convenience. Patients note receiving clear dosing instructions and syringes in every kit. No need to source supplies independently.
What Do Patients Report as Positive Experiences?
Positive reports from Ways2Well patients focus on three primary outcomes: faster recovery from chronic injuries that failed conventional treatment, improved body composition without dramatic lifestyle changes, and measurably better sleep quality within the first few weeks. These mirror the four benefit categories Buhler outlines in ‘The Peptide Revolution.’
Recovery from joint injuries receives the most consistent praise. Patients with long-standing rotator cuff, knee, and low-back issues report returning to activity after BPC-157 and TB-500 protocols when physical therapy and NSAIDs had plateaued.
So what does that mean for you? The telehealth model is specifically noted as a differentiator. Patients in states without functional medicine practitioners can access physician oversight and quality-compounded peptides via Ways2Well without traveling to Texas. The 46-state availability is a recurring positive in patient commentary.
Pros:
- Physician oversight at a $99 accessible entry point
- Third-party tested, compounding pharmacy-sourced peptides
- Personalized protocols based on actual lab bloodwork
- Full kit with vials, syringes, and dosing instructions shipped to patient
- Telehealth access across 46 states without needing to travel
- 75,000-patient observational safety record with zero adverse events reported
What Are the Common Complaints?
The most common complaints about Ways2Well center on cost, the requirement for self-injection, the lack of FDA approval for most peptides, and waitlist restrictions in four states including New York, New Jersey, Rhode Island, and Missouri. Limited published outcome data from the clinic itself is also cited.
Self-injection is a real barrier for needle-averse patients. Ways2Well provides syringes and detailed instructions, but the injectable delivery route for most peptide protocols requires consistent patient compliance. Not everyone maintains it.
Critics also point to the absence of long-term follow-up data from Buhler’s own patient population. The 75,000-patient safety claim covers adverse events. It doesn’t represent published efficacy outcomes with control comparisons. That gap in the evidence base is a fair point.
Cons:
- Most peptides are not FDA approved for marketed uses
- Self-injection required for most protocols
- Waitlist in New York, New Jersey, Rhode Island, and Missouri
- Ongoing peptide costs beyond the initial $99 consult
- No published long-term RCT efficacy data from the clinic
- International patients not currently served
Are Brigham Buhler Peptides FDA Approved?
No. Most peptides offered through Ways2Well are not FDA approved for the specific uses prescribed, and the FDA reclassified 17 to 19 peptides as ‘dangerous’ during the Biden Administration, triggering compounding restrictions that significantly reduced access. Sermorelin is the exception, holding FDA approval for growth hormone deficiency since 1997.
GLP-1 peptides like semaglutide carry full FDA approval for obesity and type 2 diabetes. The majority of performance and recovery peptides, including BPC-157, TB-500, CJC-1295, and Ipamorelin, operate in a regulatory gray zone as compounded preparations.
In plain English: the FDA approves peptides when pharmaceutical companies bring them through the full trial process. Most compounded peptides don’t have that commercial backing. That’s the structural reason for the regulatory gap, not a reflection of inherent danger.
Why Did the FDA Ban Certain Peptides?
The FDA labeled 17 to 19 peptides as ‘bulk drug substances that present demonstrable difficulties’ in 2020 and 2021, effectively restricting their compounding and distribution without presenting specific adverse event data to justify the classification. Buhler filed 17 FOIA requests seeking the safety data underlying the ban and received no response from the agency.
Buhler attributes the ban primarily to pharmaceutical industry pressure. Large companies like Eli Lilly and Novo Nordisk have filed patents on over 150 peptides. Reclassifying compounded versions as ‘dangerous’ removes lower-cost competition from the market. That’s the conflict of interest Buhler has been publicly naming for years.
Pharmaceutical drugs with documented safety risks continue to receive FDA approval and market access. Buhler contrasts this with the peptide ban, arguing that the regulatory standard applied to peptides is inconsistently stricter than what pharmaceutical products face post-approval.
Yes. Secretary Robert F. Kennedy Jr. publicly tweeted ‘the war on peptides is over,’ signaling a MAHA-aligned policy reversal that Buhler has characterized as restoring access to compounded peptides for patients and practitioners. This represents a significant shift from the Biden Administration’s stance.
Buhler was hopeful that the Kennedy-led HHS would formally reclassify peptides to restore broader access. The policy environment as of 2026 is meaningfully more favorable to compounding-based peptide therapy than it was two years earlier.
That said: formal FDA reclassification has not yet occurred for all banned peptides. The shift is directional but not complete. Patients and clinics operate in an evolving regulatory environment where access may continue to expand as administrative priorities solidify.
How Much Do Ways2Well Peptides Cost?
The entry point for Ways2Well peptide therapy is a $99 physician consultation that includes lab review and a personalized protocol, after which the company ships peptide vials with full dosing kits including syringes and instructions. Ongoing costs depend on the specific peptides prescribed and the care plan tier selected.
Care plans are tiered: Connect, Clarity, and Core, with Champion coming soon. Each tier includes progressively more comprehensive testing and clinical support. Full tier pricing is not published publicly and requires direct inquiry through the Ways2Well website.
Here’s a useful comparison: semaglutide in brand-name form costs upward of $1,000 (USD) per month without insurance. Compounded GLP-1 peptides through pharmacies like ReviveRx represent a fraction of that cost at equivalent or lower doses. The cost gap is substantial.
Ways2Well Pricing Overview:
| Service | Price | What’s Included |
| Peptide Consultation | $99 (USD) | Physician consult, lab review, personalized protocol |
| Peptide Kit Shipment | Varies by protocol | Vials, syringes, dosing instructions |
| Brand Semaglutide (comparison) | $1,000+ per month | Brand-name Ozempic or Wegovy |
| Compounded GLP-1 | Significantly lower | Compounded semaglutide from ReviveRx |
Is the $99 Peptide Consult Worth It?
Yes. The $99 consult provides access to a licensed physician who reviews bloodwork before prescribing, a standard that separates Ways2Well from unregulated online vendors who sell peptides without any clinical oversight. The physician component is the core differentiator in the pricing.
For patients dealing with chronic injuries, suboptimal sleep, or declining metabolic function, the physician-guided entry point offers a structured path to a protocol tailored to their biology. It’s not a generic online stack someone cobbled together from a forum.
The total investment goes beyond $99. Lab panels, ongoing peptide supplies, and supplementary services add to the total cost. Patients should budget for both the initial consult and recurring protocol costs before starting. The $99 is the door, not the full room.
Where Can You Buy Brigham Buhler Peptides?
Ways2Well peptides are available through Ways2Well.com via telehealth consultation in 46 states, with in-person services at the Austin location at 8226 Bee Caves Rd and the Houston location at 5307 N Main St Ste 120. Both locations operate Monday through Friday, 9am to 5pm.
The telehealth model means patients in states without local functional medicine clinics can access physician-prescribed, compounding-pharmacy-sourced peptides. The full kit ships to the patient’s address after the consult and lab review are complete.
New York, New Jersey, Rhode Island, and Missouri residents face a waitlist. State-level regulatory constraints are the reason. Patients in those states can join the waitlist through the Ways2Well website while the company works to expand access.
Ways2Well serves patients in 46 of the 50 states as of 2026, with active waitlists for New York, New Jersey, Rhode Island, and Missouri due to state-specific licensing and regulatory requirements. The company is actively working to expand into the remaining states.
Availability is confirmed at the start of the consultation process. Patients enter their state during intake, and Ways2Well determines eligibility before scheduling the physician consult or collecting any payment. No money changes hands until eligibility is confirmed.
International patients are not served by Ways2Well’s current model. The compounding pharmacy and telehealth licenses are U.S.-specific. Patients outside the United States seeking similar services would need to identify locally licensed providers following comparable protocols.
Is Ways2Well Available in Your State?
Ways2Well serves patients in 46 of the 50 states as of 2026, with active waitlists for New York, New Jersey, Rhode Island, and Missouri due to state-specific licensing requirements. The company is actively working to expand into the remaining states.
Ways2Well Locations and Availability:
- Telehealth available in 46 U.S. states
- Austin, TX: 8226 Bee Caves Rd (Mon-Fri, 9am-5pm)
- Houston, TX: 5307 N Main St Ste 120 (Mon-Fri, 9am-5pm)
- Waitlist states: New York, New Jersey, Rhode Island, Missouri
- International: not currently available
Are Brigham Buhler Peptides Worth Trying?
Who Should Try Brigham Buhler Peptides?
For patients with chronic injury, suboptimal hormonal function, or metabolic decline who have exhausted conventional options, Brigham Buhler’s physician-guided peptide protocols through Ways2Well represent a clinically supervised path to therapies with documented mechanisms and a substantial observational safety record. The evidence base isn’t equivalent to FDA-approved pharmaceuticals, but the oversight model is meaningfully different from unregulated online sourcing.
The case for trying: physician oversight, third-party tested compounded peptides, 75,000-patient observational safety data, and an entry cost of $99 that’s lower than most functional medicine consultations. The case against: most peptides remain investigational, self-injection is required, and long-term RCT data doesn’t exist yet.
Here’s what that actually means for you: the honest answer mirrors what Buhler and Rosebush write in ‘The Peptide Revolution.’ Peptides aren’t a magic solution. The combination of foundational health practices plus targeted, physician-monitored peptide therapy is the model Ways2Well is built around. Patients who approach it as one layer of a broader health strategy are the most likely to benefit.